Tomocube Inc. (475960) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tomocube Inc. (475960:KRX), powered by AI.

Current Price
₩39,950
P/E Ratio
-111.2
Market Cap
534.7B
Sector
Healthcare
What is the Tomocube Inc. stock price forecast?

Tomocube Inc. is currently trading at ₩39,950. View real-time AI analysis on Alpha Lenz.

What is Tomocube Inc. insider trading activity?

View the latest insider trading data for Tomocube Inc. on Alpha Lenz.

What is Tomocube Inc.'s P/E ratio?

Tomocube Inc.'s P/E ratio is -111.2.

Tomocube Inc.

KRX · 475960
₩39,950+1,100(+2.83%)Market closedKRX regular session 09:00–15:30 KST
Ask about Tomocube Inc.'s future dividend policy...
Alpha Chat Insight

Tomocube Inc. trades at a P/E of -111.2 (undervalued) with modest ROE of -11.9%. 3Y revenue CAGR of 82.1% highlights clear growth momentum.

Ask for details

Company Overview

Tomocube Inc. is a prominent company in the field of biotechnology and medical imaging. The firm specializes in developing advanced imaging solutions that provide three-dimensional holographic visualization and quantitative analysis of living cells. This technology is pivotal for researchers and healthcare professionals as it offers a non-invasive and detailed view of cell structures and functions, enabling better understanding and research into cellular processes and diseases. Tomocube's products are used extensively in the life sciences and medical research sectors, impacting fields such as oncology, neurology, and pharmacology. By offering cutting-edge tools for cell analysis, Tomocube Inc. plays a crucial role in advancing medical research and contributing to the development of new therapies and diagnostics. The company's innovative approach not only highlights its importance in the biotech industry but also underscores its potential to influence the future of health technology.

CEO박용근
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩534,661,796,300Market Cap
₩11,306,726,320Revenue
13.38MShares Out
0Employees

Margins

65.82%Gross
-29.56%EBITDA
-49.25%Operating
-42.54%Pre-Tax
-42.54%Net

Valuation

-111.16P/E
13.78P/B
47.29EV/Sales
-156.85EV/EBITDA
-71.02P/FCF

Growth (CAGR)

82.15%Rev 3Yr
67.48%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-11.30%ROA
-11.91%ROE
-11.13%ROIC

Financial Health

₩11,449,134,430Cash & Cash Equivalents
₩-8,731,458,640Net Debt
7.01%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tomocube Inc. (ticker: 475960) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $534.7B.

The current price is ₩39,950 with a P/E ratio of -111.16x and P/B of 13.78x.

ROE is -11.91% and operating margin is -49.25%. Annual revenue is $11.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tomocube Inc. (475960) Stock Forecast 2026 ₩39,950 — Price, Financials & Analyst Targets | Alpha Lenz